Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein?

被引：11
|
作者：
Phillips, EJ
Rachlis, AR
Ito, S
机构：
[1] Univ Toronto, Hosp Sick Children, Div Clin Pharmacol, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Div Infect Dis, Toronto, ON, Canada
[3] Univ Toronto, Hosp Sick Children, Div Toxicol, Toronto, ON, Canada
[4] Univ Toronto, Hosp Sick Children, Dept Med, Toronto, ON, Canada
[5] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
来源：
AIDS | 2003年 / 17卷 / 10期
关键词：
D O I：
10.1097/00002030-200307040-00026
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1577 / 1578
页数：2
相关论文
共 50 条
  • [21] Overcoming P-glycoprotein mediated drug resistance in glioblastoma
    Poulsen, Sally-Ann
    CANCER SCIENCE, 2021, 112 : 997 - 997
  • [22] Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk
    Lazzaro, Sarah
    West, Mark A.
    Eatemadpour, Soraya
    Feng, Bo
    Varma, Manthena V. S.
    Rodrigues, A. David
    Temesszentandrasi-Ambrus, Csilla
    Kovacs-Hajdu, Peter
    Nerada, Zsuzsanna
    Gaborik, Zsuzsanna
    Costales, Chester
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (06) : 1715 - 1723
  • [23] P-glycoprotein system as a determinant of drug interactions: The case of digoxin-verapamil
    Verschraagen, M
    Koks, CHW
    Schellens, JHM
    Beijnen, JH
    PHARMACOLOGICAL RESEARCH, 1999, 40 (04) : 301 - 306
  • [24] Absence of a pharmacokinetic interaction of rilpivirine with the P-glycoprotein substrate digoxin in healthy volunteers
    Crauwels, H.
    Deckx, H.
    Enweonye, I
    Stevens, M.
    Hoetelmans, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 58 - 59
  • [25] Macrolides interact with digoxin by inhibiting P-glycoprotein
    Reactions Weekly, 2001, 876 (1) : 3 - 3
  • [26] Toxic digoxin-drug interactions: The major role of renal p-glycoprotein
    Koren, G
    Woodland, C
    Ito, S
    VETERINARY AND HUMAN TOXICOLOGY, 1998, 40 (01) : 45 - 46
  • [27] Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein
    Ledwitch, Kaitlyn V.
    Barnes, Robert W.
    Roberts, Arthur G.
    BIOSCIENCE REPORTS, 2016, 36
  • [28] P-Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer
    Mealey, K. L.
    Fidel, J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2015, 29 (01): : 1 - 6
  • [29] Insight into the molecular mechanism of P-glycoprotein mediated drug toxicity induced by bioflavonoids: an integrated computational approach
    Wongrattanakamon, Pathomwat
    Lee, Vannajan Sanghiran
    Nimmanpipug, Piyarat
    Sirithunyalug, Busaban
    Chansakaow, Sunee
    Jiranusornkul, Supat
    TOXICOLOGY MECHANISMS AND METHODS, 2017, 27 (04) : 253 - 271
  • [30] CO-ADMINISTRATION OF QUERCETIN AND DIGOXIN: EVALUATION OF POTENTIAL NUTRIENT-DRUG INTERACTION INVOLVING THE P-GLYCOPROTEIN TRANSPORTER
    St Peter, J. V.
    Pirner, M.
    Brundage, R. C.
    Tracy, T. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S22 - S22
12345